Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q3 EPS of ($0.35), $0.03 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.